Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Amyotrophic lateral sclerosis (ALS) is a degenerative disorder of motor neurons in the cortex, brainstem and spinal cord. Its cause is unknown and it is uniformly fatal, typically within five years. About 10% of cases are inherited as an autosomal dominant trait, with high penetrance after the sixth decade. In most instances, sporadic and autosomal dominant familial ALS (FALS) are clinically similar. We have previously shown that in some but not all FALS pedigrees the disease is linked to a genetic defect on chromosome 21q (refs 8, 9). Here we report tight genetic linkage between FALS and a gene that encodes a cytosolic, Cu/Zn-binding superoxide dismutase (SOD1), a homodimeric metalloenzyme that catalyzes the dismutation of the toxic superoxide anion O2.- to O2 and H2O2 (ref. 10). Given this linkage and the potential role of free radical toxicity in other neurodenegerative disorders, we investigated SOD1 as a candidate gene in FALS. We identified 11 different SOD1 missense mutations in 13 different FALS families.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Long-standing associations of some forms of ALS with mutations in genes coding for superoxide dismutase 1”
Citations
Cites
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Orita, M., Suzuki, Y., Sekiya, T., & Hayashi, K. (1989) · Genomics · doi:10.1016/0888-7543(89)90129-8 · Cited by 3,434
DNA damage and oxygen radical toxicity
Imlay, J. A., & Linn, S. (1988) · Science · doi:10.1126/science.3287616 · Cited by 1,974
Analysis of Human Genetic Linkage.
Edwards, A. W. F., & Ott, J. (1992) · Biometrics · doi:10.2307/2532370 · Cited by 1,691
Functional inactivation of genes by dominant negative mutations
Herskowitz, I. (1987) · Nature · doi:10.1038/329219a0 · Cited by 1,160
Carlioz, A., & Touati, D. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04256.x · Cited by 784
Centre d'Etude du polymorphisme humain (CEPH): Collaborative genetic mapping of the human genome
Dausset, J., Cann, H., Cohen, D., Lathrop, M., Lalouel, J.-M., & White, R. (1990) · Genomics · doi:10.1016/0888-7543(90)90491-c · Cited by 575
Copper,zinc superoxide dismutase is primarily a cytosolic protein in human cells.
Crapo, J. D., Oury, T., Rabouille, C., Slot, J. W., & Chang, L. Y. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10405 · Cited by 503
Richardson, J., Thomas, K. A., Rubin, B. H., & Richardson, D. C. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.4.1349 · Cited by 403
Familial adult motor neuron disease: amyotrophic lateralsclerosis
(1986) · Neurology · doi:10.1212/wnl.36.4.511 · Cited by 401
Self-citation
Research works printed but not linked: 7
- Kurland, L. T. Proc. Staff Meet Mayo Clin. 32, 449–462 (1957).
- Swerts, L. & Van Den Bergh, R. J. J. genet. Hum. 24, 247–255 (1976).
- Fridovich, I. Adv. Enzym. 58, 61–97 (1986).
- Ott, J. Am. hum. Genet. 28, 528–529 (1976).
- Ott, J. Analysis of Human Genetics 203–216 (Johns Hopkins Univ. Press, Baltimore, 1991).
- Hallewell, R. A. et al. in Superoxide Dismutase in Chemistry, Biology and Medicine (ed. Rotilio, G.) 249–256 (Elsevier, 1986).
- Muller, H. in Sixth internat. Congr. Genetics (ed. Jones, D.) 213–255 (Brooklyn Botanic Gardens, Menasha, 1932).
Cited by
Items 301–400 of 1,128
Liu, J., & Wang, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01005 · Cited by 376
“Mutations in Cu/Zn superoxide dismutase 1 (SOD1), the first identified gene in ALS, characterize more than 20% of familial and 1–4% of sporadic ALS cases (1, 2).”
BackgroundThe Seeds of Neurodegeneration: Prion-like Spreading in ALS
Polymenidou, M., & Cleveland, D. W. (2011) · Cell · doi:10.1016/j.cell.2011.10.011 · Cited by 376
“The identification in 1993 of mutation in the gene encoding superoxide dismutase 1 (SOD1) as the first or second most common form of inherited ALS (Rosen et al., 1993), and subsequent generation of transgenic mice expressing ALS-causing mutants in SOD1, initiated the molecular era of deciphering disease mechanism.”
Alexianu, M. E., Ho, B., Mohamed, A. H., La Bella, V., Smith, R. G., & Appel, S. H. (1994) · Annals of Neurology · doi:10.1002/ana.410360608 · Cited by 375
Trotti, D., Rolfs, A., Danbolt, N. C., Brown, R. H., & Hediger, M. A. (1999) · Nature Neuroscience · doi:10.1038/8091 · Cited by 373
“The discovery that 15–25% of familial ALS patients have mutated Cu 2+ /Zn 2+ superoxide dismutas”
BackgroundSelf-citationGong, Y. H., Parsadanian, A. S., Andreeva, A., Snider, W. D., & Elliott, J. L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00660.2000 · Cited by 369
Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis
Dasuri, K., Zhang, L., & Keller, J. N. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.016 · Cited by 371
ALS Genetics: Gains, Losses, and Implications for Future Therapies
Kim, G., Gautier, O., Tassoni-Tsuchida, E., Ma, X. R., & Gitler, A. D. (2020) · Neuron · doi:10.1016/j.neuron.2020.08.022 · Cited by 370
“For instance, the first ALS gene that was described in 1993—superoxide dismutase 1 (SOD1)—is widely considered to cause ALS through a GOF mechanism, not only because of compelling genetic studies in animal models but also because of its dominant inheritance patterns and ability to cause protein aggregation (Bruijn et…”
BackgroundSarkar, S. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130134 · Cited by 370
Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene
Andersen, P. M. (2006) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-996-0008-9 · Cited by 368
Sanchez-Ruiz, J. M. (2010) · Biophysical Chemistry · doi:10.1016/j.bpc.2010.02.004 · Cited by 367
Bioenergetic and oxidative stress in neurodegenerative diseases
Bowling, A. C., & Beal, M. F. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00055-b · Cited by 366
The role of FUS gene variants in neurodegenerative diseases
Deng, H., Gao, K., & Jankovic, J. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.78 · Cited by 366
Self-citationWong, P. C., Waggoner, D., Subramaniam, J. R., Tessarollo, L., Bartnikas, T. B., Culotta, V. C., Price, D. L., Rothstein, J., & Gitlin, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040461197 · Cited by 364
Mitochondrial uncoupling proteins in the cns: in support of function and survival
Andrews, Z. B., Diano, S., & Horvath, T. L. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1767 · Cited by 364
“fcgi?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=20655"> SOD1”
Lee, M. K., Marszalek, J. R., & Cleveland, D. W. (1994) · Neuron · doi:10.1016/0896-6273(94)90263-1 · Cited by 366
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“…of some forms of ALS with mutations in genes coding for superoxide dismutase 1 (e.g. Dalle-Donne 2007; Pasinelli and Brown 2006; Rosen et al. 1993; Vucic and Kiernan 2009; Wijesekera and Leigh 2009) are consistent with this, and recent genetic associations (e.g. Kwiatkowski Jr.…”
BackgroundLai, E. C., Felice, K. J., Festoff, B. W., Gawel, M. J., Gelinas, D. F., Kratz, R., Murphy, M. F., Natter, H. M., Norris, F. H., Rudnicki, S. A., et al. (1997) · Neurology · doi:10.1212/wnl.49.6.1621 · Cited by 361
Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients
Wiedemann, F. R., Manfredi, G., Mawrin, C., Beal, M. F., & Schon, E. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00731.x · Cited by 359
ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage
Barzilai, A. (2002) · DNA Repair · doi:10.1016/s1568-7864(01)00007-6 · Cited by 359
Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset
Gan-Or, Z., Giladi, N., Rozovski, U., Shifrin, C., Rosner, S., Gurevich, T., Bar-Shira, A., & Orr-Urtreger, A. (2008) · Neurology · doi:10.1212/01.wnl.0000304039.11891.29 · Cited by 360
“... well as in the most common pathological subtype of frontotemporal dementia (frontotemporal lobar dementia with ubiquitinated inclusions [FTLD-U]).12 These findings have subsequently been confirmed.13–15 Evidence that TDP-43 is the major pathological protein in these conditions includes: (1) colocalization of TDP-4…”
BackgroundKeller, J. N., Mark, R. J., Bruce, A. J., Blanc, E., Rothstein, J. D., Uchida, K., Waeg, G., & Mattson, M. P. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00065-1 · Cited by 357
SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model
Harraz, M. M., Marden, J. J., Zhou, W., Zhang, Y., Williams, A., Sharov, V. S., Nelson, K., Luo, M., Paulson, H., Schöneich, C., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34060 · Cited by 356
A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia
Morita, M., Al-Chalabi, A., Andersen, P. M., Hosler, B., Sapp, P., Englund, E., Mitchell, J. E., Habgood, J. J., de Belleroche, J., Xi, J., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000200048.53766.b4 · Cited by 357
Self-citationCysteine Metabolism in Neuronal Redox Homeostasis
Paul, B. D., Sbodio, J. I., & Snyder, S. H. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.02.007 · Cited by 356
“The G93A mutation is a gain of function mutant that causes aggregation of SOD1 and degeneration of motor neurons [64, 65].”
BackgroundTilly, J. L., & Tilly, K. I. (1995) · Endocrinology · doi:10.1210/en.136.1.242 · Cited by 357
Jaarsma, D., Haasdijk, E. D., Grashorn, J. A. C., Hawkins, R., van Duijn, W., Verspaget, H. W., London, J., & Holstege, J. C. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0299 · Cited by 353
Microglia in ALS: The Good, The Bad, and The Resting
Henkel, J. S., Beers, D. R., Zhao, W., & Appel, S. H. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9171-5 · Cited by 353
“One form of fALS is caused by missense mutations in the gene encoding the enzyme Cu2+/Zn2+ superoxide dismutase (SOD1), which induces disease by a toxic gain of function and not by a loss of enzymatic activity (Borchelt et al. 1994; Rosen et al. 1993).”
BackgroundRyu, H., Smith, K., Camelo, S. I., Carreras, I., Lee, J., Iglesias, A. H., Dangond, F., Cormier, K. A., Cudkowicz, M. E., H. Brown, R., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03077.x · Cited by 353
The epidemiology of amyotrophic lateral sclerosis
(2016) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-802973-2.00013-6 · Cited by 353
Deng, H., Zhai, H., Bigio, E. H., Yan, J., Fecto, F., Ajroud, K., Mishra, M., Ajroud‐Driss, S., Heller, S., Sufit, R., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22051 · Cited by 352
Self-citationAntisense Oligonucleotide Therapies for Neurodegenerative Diseases
Bennett, C. F., Krainer, A. R., & Cleveland, D. W. (2019) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070918-050501 · Cited by 353
“The first gene to be identified that causes familial ALS was SOD1, which accounts for approximately 20% of familial ALS cases (Rosen et al. 1993).”
BackgroundGlutamate transporters: animal models to neurologic disease
Maragakis, N. J., & Rothstein, J. D. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.007 · Cited by 352
Lost in translation: Treatment trials in the SOD1 mouse and in human ALS
Benatar, M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.12.015 · Cited by 350
Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice
Brown, R. H. (1995) · Cell · doi:10.1016/0092-8674(95)90346-1 · Cited by 352
Self-citationSankowski, R., Mader, S., & Valdés-Ferrer, S. I. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00028 · Cited by 351
“…HDLS (Rademakers et al., 2012) Microglial proliferation and differentiation (Stanley et al., 1997) Myeloid cells Loss-of-function SOD1 fALS (Rosen, 1993) O2− scavenging Ubiquitous Loss-of-function (Ghadge et al., 1997; Pasinelli et al., 1998) GRN Tau negative FTD (Baker et al., 2006)…”
BackgroundUnderstanding the role of TDP-43 and FUS/TLS in ALS and beyond
Da Cruz, S., & Cleveland, D. W. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.05.029 · Cited by 351
Atkin, J. D., Farg, M. A., Walker, A. K., McLean, C., Tomas, D., & Horne, M. K. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.02.009 · Cited by 350
RetractedMitochondria in Neurodegeneration: Acute Ischemia and Chronic Neurodegenerative Diseases
Fiskum, G., Murphy, A. N., & Beal, M. F. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199904000-00001 · Cited by 350
Protein Quality Control by Molecular Chaperones in Neurodegeneration
Ciechanover, A., & Kwon, Y. T. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00185 · Cited by 346
“Amongst these, the mutations of SOD1, a free radical scavenger enzyme, accounts for 20% of familial ALS cases (Rosen et al., 1993).”
BackgroundKannaiyan, R., Shanmugam, M. K., & Sethi, G. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.10.025 · Cited by 346
Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22.
Wilhelmsen, K. C., Lynch, T., Pavlou, E., Higgins, M., & Nygaard, T. G. (1994) · PubMed Central · Cited by 396
Huntington's disease gene (IT15) is widely expressed in human and rat tissues
Li, S.-H., Schilling, G., Young, W. S., Li, X., Margolis, R. L., Stine, O. C., Wagster, M. V., Abbott, M. H., Franz, M. L., Ranen, N. G., et al. (1993) · Neuron · doi:10.1016/0896-6273(93)90127-d · Cited by 347
Hypermetabolism in ALS patients: an early and persistent phenomenon
Bouteloup, C., Desport, J.-C., Clavelou, P., Guy, N., Derumeaux-Burel, H., Ferrier, A., & Couratier, P. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5100-z · Cited by 344
“Moreover, a range of findings point to an alteration in radical oxygen species (ROS) homeostasis under oxidative stress [11, 15].”
BackgroundBoeve, B. F., Boylan, K. B., Graff-Radford, N. R., DeJesus-Hernandez, M., Knopman, D. S., Pedraza, O., Vemuri, P., Jones, D., Lowe, V., Murray, M. E., et al. (2012) · Brain · doi:10.1093/brain/aws004 · Cited by 345
“Familial frontotemporal dementia (FTD) with or without parkinsonism has been associated with mutations in genes encoding microtubule associated protein tau (MAPT), progranulin (PGRN), and less commonly valosin-containing protein, TAR DNA-binding protein (TDP) and fused in sarcoma (FUS) while familial amyotrophic later…”
BackgroundPasinelli, P., Houseweart, M. K., Brown, R. H., & Cleveland, D. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240305897 · Cited by 345
Self-citationMotor neuron vulnerability and resistance in amyotrophic lateral sclerosis
Nijssen, J., Comley, L. H., & Hedlund, E. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1708-8 · Cited by 339
“The first gene discovered to harbour mutations causing fALS was the Cu/Zn superoxide dismutase 1 (SOD1) gene [153].”
BackgroundMori, K., Lammich, S., Mackenzie, I. R. A., Forné, I., Zilow, S., Kretzschmar, H., Edbauer, D., Janssens, J., Kleinberger, G., Cruts, M., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1088-7 · Cited by 342
“Besides TDP-43 and the long known SOD1 (super oxide dismutase 1) gene [30], a number of other ALS and/or FTLD-related genes/risk factors were discovered including FUS (fused in sarcoma) [20, 40], OPTN (optineurin) [23], Ataxin 2 [11], Chmp2B [35], VCP (valosin containing protein) [41], TMEM106B [38], GRN (progranulin)…”
BackgroundGenetic Classification of Primary Neurodegenerative Disease
Hardy, J., & Gwinn-Hardy, K. (1998) · Science · doi:10.1126/science.282.5391.1075 · Cited by 343
An iron-sulfur center essential for transcriptional activation by the redox-sensing SoxR protein.
Hidalgo, E., & Demple, B. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06243.x · Cited by 340
Zinc homeostasis and functions of zinc in the brain
Takeda, A. (2001) · Biometals · doi:10.1023/a:1012982123386 · Cited by 340
Copper: Effects of Deficiency and Overload
Scheiber, I., Dringen, R., & Mercer, J. F. B. (2013) · Metal Ions in Life Sciences · doi:10.1007/978-94-007-7500-8_11 · Cited by 328
Deregulation of Cdk5 in a Mouse Model of ALS
Nguyen, M. D., Larivière, R. C., & Julien, J.-P. (2001) · Neuron · doi:10.1016/s0896-6273(01)00268-9 · Cited by 338
Ajami, B., Samusik, N., Wieghofer, P., Ho, P. P., Crotti, A., Bjornson, Z., Prinz, M., Fantl, W. J., Nolan, G. P., & Steinman, L. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0100-x · Cited by 338
Mitochondrial DNA repair and aging
Mandavilli, B. S., Santos, J. H., & Van Houten, B. (2002) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(02)00220-8 · Cited by 338
Aoyama, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095010 · Cited by 336
“Mutations in SOD1 cause ALS in humans [113], and the overexpression of the ALSlinked mutant hSOD1 also causes an ALS-like phenotype in rodents [114].”
BackgroundRole of Oxidative Stress and Antioxidants in Neurodegenerative Diseases
Rao, A. V., & Balachandran, B. (2002) · Nutritional Neuroscience · doi:10.1080/1028415021000033767 · Cited by 336
Aoyama, T., Paik, Y.-H., Watanabe, S., Laleu, B., Gaggini, F., Fioraso-Cartier, L., Molango, S., Heitz, F., Merlot, C., Szyndralewiez, C., et al. (2012) · Hepatology · doi:10.1002/hep.25938 · Cited by 336
Cui, K., Luo, X., Xu, K., & Ven Murthy, M. R. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.023 · Cited by 336
Rabizadeh, S., Gralla, E. B., Borchelt, D. R., Gwinn, R., Valentine, J. S., Sisodia, S., Wong, P., Lee, M., Hahn, H., & Bredesen, D. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.3024 · Cited by 335
Increased oxidative damage to DNA in ALS patients
Bogdanov, M., Brown, R. H., Matson, W., Smart, R., Hayden, D., O’Donnell, H., Flint Beal, M., & Cudkowicz, M. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00349-x · Cited by 334
Self-citationThe effect of deprenyl and levodopa on the progression of Parkinson's disease
Olanow, C. W., Hauser, R. A., Gauguster, L., Malapira, T., Koller, W., Hubble, J., Bushenbark, K., Lilienfeld, D., & Esterlitz, J. (1995) · Annals of Neurology · doi:10.1002/ana.410380512 · Cited by 334
Inhibition of ICE slows ALS in mice
Friedlander, R. M., Brown, R. H., Gagliardini, V., Wang, J., & Yuan, J. (1997) · Nature · doi:10.1038/40299 · Cited by 332
Self-citationOxidative damage to protein in sporadic motor neuron disease spinal cord
Shaw, P. J., Ince, P. G., Falkous, G., & Mantle, D. (1995) · Annals of Neurology · doi:10.1002/ana.410380424 · Cited by 331
“seminated carcinoma with bronchopneumonia (2), and rapid death following a fall with multiple injuries (1).”
BackgroundA role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis
Barbeito, L. H., Pehar, M., Cassina, P., Vargas, M. R., Peluffo, H., Viera, L., Estévez, A. G., & Beckman, J. S. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.05.003 · Cited by 327
Crippa, V., Sau, D., Rusmini, P., Boncoraglio, A., Onesto, E., Bolzoni, E., Galbiati, M., Fontana, E., Marino, M., Carra, S., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq257 · Cited by 330
“More than 80% of ALS cases are sporadic (sALS); among the rare familial forms (fALS) about one-fifth have been associated to Cu/Zn superoxide dismutase 1 (SOD1) gene mutations (3) and even less to mutations in the gene coding for TDP-43 (a protein found as a major constituent in inclusions of sALS as well as non-SOD1-…”
BackgroundOxidative stress in spinal cord injury and antioxidant-based intervention
Jia, Z., Zhu, H., Li, J., Wang, X., Misra, H., & Li, Y. (2012) · Spinal Cord · doi:10.1038/sc.2011.111 · Cited by 329
The SLC1 high-affinity glutamate and neutral amino acid transporter family
Kanai, Y., Clémençon, B., Simonin, A., Leuenberger, M., Lochner, M., Weisstanner, M., & Hediger, M. A. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.01.001 · Cited by 329
Leigh, P. N., & Ray-Chaudhuri, K. (1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.8.886 · Cited by 331
Apoptosis in Neural Development and Disease
Nijhawan, D., Honarpour, N., & Wang, X. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.73 · Cited by 328
Tam, O. H., Rozhkov, N. V., Shaw, R., Kim, D., Hubbard, I., Fennessey, S., Propp, N., Phatnani, H., Kwan, J., Sareen, D., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.066 · Cited by 327
“An example is SOD1, which has been ascribed roles in oxidative stress (Rosen et al., 1993), proteotoxic stress (Bruijn et al.”
ESPOSITO, E., ROTILIO, D., DIMATTEO, V, DIGIULIO, C., CACCHIO, M., & ALGERI, S. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00078-7 · Cited by 326
“The drug riluzole, which inhibits glutamate release at presynaptic terminals, also extends lifespan slightly in human mSOD-1 G93A transgenic mice [95].”
BackgroundInfluentialNrf2—a therapeutic target for the treatment of neurodegenerative diseases
Johnson, D. A., & Johnson, J. A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.07.147 · Cited by 321
“The first mutant gene identified in fALS was Cu/Zn-superoxide dismutase 1 (SOD1) and the mutation caused disease through a toxic gain of function [129].”
BackgroundAn estimate of amyotrophic lateral sclerosis heritability using twin data
Al-Chalabi, A., Fang, F., Hanby, M. F., Leigh, P. N., Shaw, C. E., Ye, W., & Rijsdijk, F. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.207464 · Cited by 323
Glutamate Transporters in Neurologic Disease
Maragakis, N. J., & Rothstein, J. D. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.365 · Cited by 324
“Evidence for glutamate contributing to motor neuron degeneration in ALS initially came from several studies that suggested that cerebrospinal fluid glutamate levels may be elevated in patients with sporadic ALS.20,21 These earlier studies reported that motor cortex and spinal cord tissue glutamate levels were decrease…”
InfluentialClinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis
D’Amico, E., Factor-Litvak, P., Santella, R. M., & Mitsumoto, H. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.029 · Cited by 321
“TDP-43 inclusions are now known to be present in the majority of ALS cases, including ALS-FTD, sALS, non-SOD1 fALS, and the ALS-Parkinson disease (PD) complex in Guam [178–181].”
InfluentialMutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis
Pesiridis, G. S., Lee, V. M.-Y., & Trojanowski, J. Q. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp303 · Cited by 324
Andersen, P. M., Nilsson, P., Ala-Hurula, V., Keränen, M.-L., Tarvainen, I., Haltia, T., Nilsson, L., Binzer, M., Forsgren, L., & Marklund, S. L. (1995) · Nature Genetics · doi:10.1038/ng0595-61 · Cited by 322
Novel Antibodies Reveal Inclusions Containing Non-Native SOD1 in Sporadic ALS Patients
Forsberg, K., Jonsson, P. A., Andersen, P. M., Bergemalm, D., Graffmo, K. S., Hultdin, M., Jacobsson, J., Rosquist, R., Marklund, S. L., & Brännström, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011552 · Cited by 320
“Approximately 10% of ALS patients are familial (FALS) [1] and in 12–23% of these the disease has been linked to mutations in the gene for CuZn-superoxide dismutase (SOD1) [2].”
BackgroundHegedus, J., Putman, C. T., & Gordon, T. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.003 · Cited by 321
“Approximately 10% of ALS cases are familial (fALS), and of these, 20% have been linked to mutations of the superoxide dismutase (SOD) gene (Rosen, 1993).”
BackgroundMethodNagai, M., Aoki, M., Miyoshi, I., Kato, M., Pasinelli, P., Kasai, N., Brown, R. H., & Itoyama, Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09246.2001 · Cited by 320
“In 25% of familial cases, the disease is caused by mutations in the gene encoding cytosolic copper–zinc superoxide dismutase (SOD1) (Rosen et al., 1993).”
BackgroundSelf-citationEmerging mechanisms of molecular pathology in ALS
Peters, O. M., Ghasemi, M., & Brown, R. H. (2015) · Journal of Clinical Investigation · doi:10.1172/jci71601 · Cited by 313
Self-citationDrosophila as an In Vivo Model for Human Neurodegenerative Disease
McGurk, L., Berson, A., & Bonini, N. M. (2015) · Genetics · doi:10.1534/genetics.115.179457 · Cited by 318
“The first gene mutations associated with ALS were identified in SOD1, a metabolic gene encoding for copper/zinc ion binding superoxide dismutase (Rosen et al. 1993).”
BackgroundTBK1: a new player in ALS linking autophagy and neuroinflammation
Oakes, J. A., Davies, M. C., & Collins, M. O. (2017) · Molecular Brain · doi:10.1186/s13041-017-0287-x · Cited by 319
Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis
Kaur, S. J., McKeown, S. R., & Rashid, S. (2016) · Gene · doi:10.1016/j.gene.2015.11.049 · Cited by 315
Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons
Chen, H., Qian, K., Du, Z., Cao, J., Petersen, A., Liu, H., Blackbourn, L. W., Huang, C.-L., Errigo, A., Yin, Y., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.02.004 · Cited by 318
“While mostly sporadic, a small population of patients is associated with genetic mutations, among which 20% are caused by mutations in the Cu/Zn superoxide dismutase (SOD1) gene (Rosen et al., 1993; Deng et al., 1993).”
Wong, M., & Martin, L. J. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq106 · Cited by 314
“Mutations in the superoxide dismutase-1 (SOD1) gene account for 20% of all fALS cases ( 2% of all ALS cases) (4,5).”
BackgroundIs SOD1 loss of function involved in amyotrophic lateral sclerosis?
Saccon, R. A., Bunton-Stasyshyn, R. K. A., Fisher, E. M. C., & Fratta, P. (2013) · Brain · doi:10.1093/brain/awt097 · Cited by 317
“The finding of loss of dismutase activity in patients with ALS and the distribution of ALS-causative mutations spread throughout the SOD1 gene initially suggested loss of function as a mechanism (Deng et al., 1993; Rosen et al., 1993).”
BackgroundGenetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases
Migliore, L., & Coppedè, F. (2009) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2008.10.011 · Cited by 317
Elam, J. S., Taylor, A. B., Strange, R., Antonyuk, S., Doucette, P. A., Rodriguez, J. A., Hasnain, S. S., Hayward, L. J., Valentine, J. S., Yeates, T. O., et al. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb935 · Cited by 316
“Of all ALS cases, ∼10% are familial, and ∼20% of these familial ALS (FALS) cases are associated with dominantly inherited mutations in copper-zinc superoxide dismutase (SOD1”
Background4-Hydroxynonenal and neurodegenerative diseases
Zarkovic, K. (2003) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(03)00024-4 · Cited by 315
Misfolded Mutant SOD1 Directly Inhibits VDAC1 Conductance in a Mouse Model of Inherited ALS
Israelson, A., Arbel, N., Da Cruz, S., Ilieva, H., Yamanaka, K., Shoshan-Barmatz, V., & Cleveland, D. W. (2010) · Neuron · doi:10.1016/j.neuron.2010.07.019 · Cited by 315
“Twenty percent of these familial cases have been attributed tomutations in the gene encoding cytoplasmic Cu/Zn superoxide dismutase (SOD1) (Rosen et al., 1993).”
BackgroundHosler, B. A. (2000) · JAMA · doi:10.1001/jama.284.13.1664 · Cited by 315
“3 [2-24]) years, with most persons surviving 6 years or less and with 3 patients surviving 12, 13, and 24 years, respectively.”
BackgroundShukla, S., & Tekwani, B. L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00537 · Cited by 314
Pardo, C. A., Xu, Z., Borchelt, D. R., Price, D. L., Sisodia, S. S., & Cleveland, D. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.954 · Cited by 314
Genetics of motor neuron disorders: new insights into pathogenic mechanisms
Dion, P. A., Daoud, H., & Rouleau, G. A. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2680 · Cited by 313
“Mendelian ALS involving SOD1 Our understanding of the molecular and genetic basis of ALS began with the identification of mutations in SOD1 (Ref”
BackgroundSelf-citationSuperoxide Radicals in the Execution of Cell Death
Fujii, J., Homma, T., & Osaki, T. (2022) · Antioxidants · doi:10.3390/antiox11030501 · Cited by 305
“However, there still remains ambiguities regarding the mechanism responsible for how mutant SOD1 causes FALS, and studies on this issue are now underway from the perspective of basic and clinical medicine.”
BackgroundInfluentialMolecular and cellular pathways of neurodegeneration in motor neurone disease
Shaw, P. J. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.048652 · Cited by 308
Siklós, L., Engelhardt, J., Harati, Y., Smith, R. G., Joó, F., & Appel, S. H. (1996) · Annals of Neurology · doi:10.1002/ana.410390210 · Cited by 310
Vercelli, A., Mereuta, O. M., Garbossa, D., Muraca, G., Mareschi, K., Rustichelli, D., Ferrero, I., Mazzini, L., Madon, E., & Fagioli, F. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.05.016 · Cited by 309
“The breeding pairs were purchased from the Jackson Laboratory (Bar Harbor, ME, USA) and the transgenic mice were genotyped using a described polymerase chain reaction (PCR) method (Rosen et al., 1993).”
BackgroundMethodMillecamps, S., Salachas, F., Cazeneuve, C., Gordon, P., Bricka, B., Camuzat, A., Guillot-Noël, L., Russaouen, O., Bruneteau, G., Pradat, P.-F., et al. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2010.077180 · Cited by 311
“The first identified was the SOD1 gene, which encodes cooper/zinc superoxide dismutase.(1) More than 130 mutations, which account for 12e23% of familial ALS (FALS), have now been reported (http://alsod.”
BackgroundSelf-citation
Metadata
- Authors
- Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., Rahmani, Z., Krizus, A., McKenna-Yasek, D., Cayabyab, A., Gaston, S. M., Berger, R., Tanzi, R. E., Halperin, J. J., Herzfeldt, B., Van den Bergh, R., Hung, W.-Y., Bird, T., Deng, G., Mulder, D. W., Smyth, C., Laing, N. G., Soriano, E., Pericak–Vance, M. A., Haines, J., Rouleau, G. A., Gusella, J. S., Horvitz, H. R., & Brown, R. H.
- Affiliations
- Massachusetts General Hospital (US)
- Northwestern University (US)
- Montreal General Hospital (CA)
- Howard Hughes Medical Institute (US)
- North Shore University Hospital (US)
- University of Washington (US)
- Mayo Clinic (US)
- ORCID
- Venue
- Nature
- Published
- 1993-03-01
- Volume
- 362
- Issue
- 6415
- Pages
- 59-62
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2096386031
- Cited by
- 7,062
- References
- 42
- Citations by year
- 2026: 137 · 2025: 154 · 2024: 201 · 2023: 185 · 2022: 254 · 2021: 259 · 2020: 295 · 2019: 205 · 2018: 258 · 2017: 248 · 2016: 242 · 2015: 248 · 2014: 262 · 2013: 264 · 2012: 315
- FWCI
- 174.77
- Type
- journal article
- Language
- en
- Update notices
- correction (1993-07-22)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- amyotrophic lateral sclerosis, familial ALS, SOD1, Cu/Zn superoxide dismutase, missense mutations, genetic linkage, chromosome 21q, autosomal dominant inheritance, free radical toxicity, candidate genes, motor neuron degeneration
- MeSH terms
- Amino Acid Sequence, Amyotrophic Lateral Sclerosis, Animals, Base Sequence, Codon, DNA, Exons, Humans, Isoenzymes, Lod Score, Molecular Sequence Data, Mutation, Nucleic Acid Conformation, Oligodeoxyribonucleotides, Polymorphism, Genetic, Repetitive Sequences, Nucleic Acid, Superoxide Dismutase, Genome, Human, Polymerase Chain Reaction, Sequence Homology, Amino Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.